106 related articles for article (PubMed ID: 12777736)
21. Angiogenesis in chronic liver disease and its complications.
Coulon S; Heindryckx F; Geerts A; Van Steenkiste C; Colle I; Van Vlierberghe H
Liver Int; 2011 Feb; 31(2):146-62. PubMed ID: 21073649
[TBL] [Abstract][Full Text] [Related]
22. Loss of HIF-1alpha in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis.
Tang N; Wang L; Esko J; Giordano FJ; Huang Y; Gerber HP; Ferrara N; Johnson RS
Cancer Cell; 2004 Nov; 6(5):485-95. PubMed ID: 15542432
[TBL] [Abstract][Full Text] [Related]
23. Peptide-based molecules in angiogenesis.
D'Andrea LD; Del Gatto A; Pedone C; Benedetti E
Chem Biol Drug Des; 2006 Feb; 67(2):115-26. PubMed ID: 16492159
[TBL] [Abstract][Full Text] [Related]
24. Regulation of angiogenesis by Id-1 through hypoxia-inducible factor-1alpha-mediated vascular endothelial growth factor up-regulation in hepatocellular carcinoma.
Lee TK; Poon RT; Yuen AP; Ling MT; Wang XH; Wong YC; Guan XY; Man K; Tang ZY; Fan ST
Clin Cancer Res; 2006 Dec; 12(23):6910-9. PubMed ID: 17145808
[TBL] [Abstract][Full Text] [Related]
25. Noninvasive tracer techniques to characterize angiogenesis.
Haubner R
Handb Exp Pharmacol; 2008; (185 Pt 2):323-39. PubMed ID: 18626609
[TBL] [Abstract][Full Text] [Related]
26. Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor.
Mousa SA; Bergh JJ; Dier E; Rebbaa A; O'Connor LJ; Yalcin M; Aljada A; Dyskin E; Davis FB; Lin HY; Davis PJ
Angiogenesis; 2008; 11(2):183-90. PubMed ID: 18080776
[TBL] [Abstract][Full Text] [Related]
27. Uncontrolled expression of vascular endothelial growth factor and its receptors leads to insufficient skin angiogenesis in patients with systemic sclerosis.
Distler O; Distler JH; Scheid A; Acker T; Hirth A; Rethage J; Michel BA; Gay RE; Müller-Ladner U; Matucci-Cerinic M; Plate KH; Gassmann M; Gay S
Circ Res; 2004 Jul; 95(1):109-16. PubMed ID: 15178641
[TBL] [Abstract][Full Text] [Related]
28. Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth.
Fahmy RG; Dass CR; Sun LQ; Chesterman CN; Khachigian LM
Nat Med; 2003 Aug; 9(8):1026-32. PubMed ID: 12872165
[TBL] [Abstract][Full Text] [Related]
29. Hypoxia-inducible factor 1 alpha expression correlates with angiogenesis and unfavorable prognosis in bladder cancer.
Theodoropoulos VE; Lazaris ACh; Sofras F; Gerzelis I; Tsoukala V; Ghikonti I; Manikas K; Kastriotis I
Eur Urol; 2004 Aug; 46(2):200-8. PubMed ID: 15245814
[TBL] [Abstract][Full Text] [Related]
30. Macrophage infiltration and angiogenesis in human malignancy.
Knowles H; Leek R; Harris AL
Novartis Found Symp; 2004; 256():189-200; discussion 200-4, 259-69. PubMed ID: 15027491
[TBL] [Abstract][Full Text] [Related]
31. HIF at the crossroads between ischemia and carcinogenesis.
Paul SA; Simons JW; Mabjeesh NJ
J Cell Physiol; 2004 Jul; 200(1):20-30. PubMed ID: 15137054
[TBL] [Abstract][Full Text] [Related]
32. [Value of angiogenesis inhibitors in tumor diseases--preclinical data]].
Berdel WE; Panse J
Onkologie; 2005 Oct; 28 Suppl 4():25-8. PubMed ID: 16205102
[No Abstract] [Full Text] [Related]
33. [Overload damage to the Achilles tendon: the importance of vascularization and angiogenesis].
Petersen W; Pufe T; Pfrommer S; Tillmann B
Orthopade; 2005 Jun; 34(6):533-42. PubMed ID: 15926081
[TBL] [Abstract][Full Text] [Related]
34. Wielding more power over angiogenesis.
Habeck M
Mol Med Today; 2000 Apr; 6(4):138-9. PubMed ID: 10740249
[No Abstract] [Full Text] [Related]
35. [Advances of vasculogenic mimicry in tumors].
Zhang SW; Sun BC
Zhonghua Bing Li Xue Za Zhi; 2007 Oct; 36(10):694-7. PubMed ID: 18194606
[No Abstract] [Full Text] [Related]
36. Intratumoral hypoxia, radiation resistance, and HIF-1.
Semenza GL
Cancer Cell; 2004 May; 5(5):405-6. PubMed ID: 15144945
[TBL] [Abstract][Full Text] [Related]
37. Competing pathways of iron chelation: angiogenesis or anti-tumor activity: targeting different molecules to induce specific effects.
Le NT; Richardson DR
Int J Cancer; 2004 Jun; 110(3):468-9. PubMed ID: 15095318
[No Abstract] [Full Text] [Related]
38. Antiangiogenic therapy and tumor progression.
Blagosklonny MV
Cancer Cell; 2004 Jan; 5(1):13-7. PubMed ID: 14749122
[TBL] [Abstract][Full Text] [Related]
39. ADAMTS9 is a cell-autonomously acting, anti-angiogenic metalloprotease expressed by microvascular endothelial cells.
Koo BH; Coe DM; Dixon LJ; Somerville RP; Nelson CM; Wang LW; Young ME; Lindner DJ; Apte SS
Am J Pathol; 2010 Mar; 176(3):1494-504. PubMed ID: 20093484
[TBL] [Abstract][Full Text] [Related]
40. New insights in the modulation of tumor angiogenesis.
Presta M; Ribatti D
Eur Cytokine Netw; 2009 Dec; 20(4):157. PubMed ID: 20167553
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
